{"id":61685,"date":"2023-12-04T11:22:57","date_gmt":"2023-12-04T02:22:57","guid":{"rendered":"https:\/\/monolith.law\/tr\/?p=61685"},"modified":"2024-03-16T16:42:40","modified_gmt":"2024-03-16T07:42:40","slug":"medical-institution-reward-law","status":"publish","type":"post","link":"https:\/\/monolith.law\/tr\/internet\/medical-institution-reward-law","title":{"rendered":"G\u00fczellik Esteti\u011fi Yorumlar\u0131na \u00d6d\u00fcl Verilmesi Kabul Edilebilir mi? Site Y\u00f6netiminde Gizli Yasal Riskler"},"content":{"rendered":"\n<p>G\u00fczellik esteti\u011fi yapt\u0131ran hastalardan bir\u00e7ok yorum ve inceleme al\u0131nan g\u00fczellik odakl\u0131 yorum siteleri. Son zamanlarda, \u00e7e\u015fitli yorum sitelerinin say\u0131s\u0131 artm\u0131\u015ft\u0131r, ancak bunlar\u0131n i\u00e7inde, inceleme yay\u0131nlaman\u0131n kar\u015f\u0131l\u0131\u011f\u0131nda t\u0131bbi kurulu\u015flardan \u00f6deme alan durumlar olabilir.<\/p>\n\n\n\n<p>Peki, yorum sitelerinin, t\u0131bbi kurulu\u015flardan inceleme kar\u015f\u0131l\u0131\u011f\u0131nda \u00f6deme almas\u0131 eylemi hukuka ayk\u0131r\u0131 m\u0131d\u0131r? Bunu ayr\u0131 ayr\u0131 a\u00e7\u0131kl\u0131yoruz.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_53 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/monolith.law\/tr\/internet\/medical-institution-reward-law\/#Sorunun_Yeri\" title=\"Sorunun Yeri\">Sorunun Yeri<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/monolith.law\/tr\/internet\/medical-institution-reward-law\/#Japon_Saglik_Reklamcilik_Kilavuzu_Madde_3_%E2%80%98Yasaklanan_Reklamlar%E2%80%99\" title=\" Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k K\u0131lavuzu Madde 3 &#8216;Yasaklanan Reklamlar&#8217;\"> Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k K\u0131lavuzu Madde 3 &#8216;Yasaklanan Reklamlar&#8217;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/monolith.law\/tr\/internet\/medical-institution-reward-law\/#Tibbi_Hukuk_Madde_54_%E2%80%98Fazla_Kar_Dagitiminin_Yasaklanmasi%E2%80%99\" title=\"T\u0131bbi Hukuk Madde 54 &#8216;Fazla Kar Da\u011f\u0131t\u0131m\u0131n\u0131n Yasaklanmas\u0131&#8217;\">T\u0131bbi Hukuk Madde 54 &#8216;Fazla Kar Da\u011f\u0131t\u0131m\u0131n\u0131n Yasaklanmas\u0131&#8217;<\/a><ul class='ez-toc-list-level-4'><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/monolith.law\/tr\/internet\/medical-institution-reward-law\/#Hedef_Alinan_Tibbi_Kuruluslar\" title=\"Hedef Al\u0131nan T\u0131bbi Kurulu\u015flar\">Hedef Al\u0131nan T\u0131bbi Kurulu\u015flar<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/monolith.law\/tr\/internet\/medical-institution-reward-law\/#Saglikla_Ilgili_Sitelerin_Karsilastirilmasi\" title=\"Sa\u011fl\u0131kla \u0130lgili Sitelerin Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131\">Sa\u011fl\u0131kla \u0130lgili Sitelerin Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/monolith.law\/tr\/internet\/medical-institution-reward-law\/#Saglik_kurumlarindan_inceleme_karsiliginda_odul_almak_yasal_mi\" title=\"Sa\u011fl\u0131k kurumlar\u0131ndan inceleme kar\u015f\u0131l\u0131\u011f\u0131nda \u00f6d\u00fcl almak yasal m\u0131?\">Sa\u011fl\u0131k kurumlar\u0131ndan inceleme kar\u015f\u0131l\u0131\u011f\u0131nda \u00f6d\u00fcl almak yasal m\u0131?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/monolith.law\/tr\/internet\/medical-institution-reward-law\/#Ozet\" title=\"\u00d6zet\">\u00d6zet<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sorunun_Yeri\"><\/span>Sorunun Yeri<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Yorum sitelerini kullan\u0131rken, tedavi i\u00e7eri\u011fi hakk\u0131ndaki d\u00fc\u015f\u00fcnceler, tedavi \u00f6ncesi ve sonras\u0131 kar\u015f\u0131la\u015ft\u0131rma resimleri gibi bir\u00e7ok yorum yay\u0131nlanmaktad\u0131r. G\u00fczellikle ilgili yorum sitelerinin i\u015fletilmesinde, hastalara yorumlar ve foto\u011fraflar i\u00e7in \u00f6deme yap\u0131l\u0131rken, t\u0131bbi kurulu\u015flardan \u00f6deme al\u0131nan durumlar olabiliyor ve bu t\u00fcr eylemler hukuki riskler olu\u015fturabiliyor. \u0130lgili d\u00fczenlemeler a\u015fa\u011f\u0131daki iki noktada toplanmaktad\u0131r.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Japon_Saglik_Reklamcilik_Kilavuzu_Madde_3_%E2%80%98Yasaklanan_Reklamlar%E2%80%99\"><\/span> Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k K\u0131lavuzu Madde 3 &#8216;Yasaklanan Reklamlar&#8217;<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p> Sa\u011fl\u0131k kurulu\u015flar\u0131n\u0131n reklam yay\u0131nlarken uymas\u0131 gereken standartlar olarak, Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k K\u0131lavuzu bulunmaktad\u0131r. Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k K\u0131lavuzu, Japon Sa\u011fl\u0131k Hukuku&#8217;nun d\u00fczenlemelerini somutla\u015ft\u0131ran bir belge olarak kabul edilebilir.<\/p>\n\n\n\n<p> Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k K\u0131lavuzu, &#8220;Hastalar\u0131n veya di\u011fer ki\u015filerin subjektif g\u00f6r\u00fc\u015flerine veya duyumlar\u0131na dayal\u0131 tedavi i\u00e7erikleri veya etkileri hakk\u0131ndaki deneyimlerin reklam\u0131 ve tedavi \u00f6ncesi ve sonras\u0131 foto\u011fraflar gibi, hastalar\u0131n veya di\u011fer ki\u015filerin yan\u0131lt\u0131c\u0131 olabilecek tedavi i\u00e7erikleri veya etkileri hakk\u0131ndaki reklamlar\u0131n yasaklanmas\u0131&#8221; gerekti\u011fini belirtmektedir.<\/p>\n\n\n\n<p> Kullan\u0131c\u0131 yorumlar\u0131 ve tedavi \u00f6ncesi ve sonras\u0131 foto\u011fraflar\u0131n bu k\u0131lavuza ayk\u0131r\u0131 olup olmad\u0131\u011f\u0131 hakk\u0131nda detayl\u0131 bir a\u00e7\u0131klama burada bulunmaktad\u0131r, l\u00fctfen okuyunuz.<\/p>\n\n\n\n<p><a href=\"https:\/\/monolith.law\/corporate\/cosmetic-surgery-image-point\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/monolith.law\/corporate\/cosmetic-surgery-image-point[ja]<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tibbi_Hukuk_Madde_54_%E2%80%98Fazla_Kar_Dagitiminin_Yasaklanmasi%E2%80%99\"><\/span>T\u0131bbi Hukuk Madde 54 &#8216;Fazla Kar Da\u011f\u0131t\u0131m\u0131n\u0131n Yasaklanmas\u0131&#8217;<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2020\/07\/medical-institution-reward-law5.jpg\" alt=\"\" class=\"wp-image-14444\" \/><\/figure>\n\n\n\n<p>T\u0131bbi kurulu\u015flar, normal \u015firketlere k\u0131yasla kabul edilebilir faaliyet alanlar\u0131n\u0131n daha dar oldu\u011fu bir \u00f6zellik ta\u015f\u0131r. T\u0131bbi Hukukun 54. maddesi, kar pe\u015finde ko\u015fma ve fazla kar da\u011f\u0131t\u0131m\u0131 gibi, bir \u015firket i\u00e7in do\u011fal olarak kabul edilen faaliyetlere izin vermez.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>Madde 54: T\u0131bbi kurulu\u015flar, fazla kar da\u011f\u0131tmamal\u0131d\u0131r.<\/p>\n<cite>http:\/\/www.jscm.org\/m-info\/07_iryouhou.pdf<\/cite><\/blockquote>\n\n\n\n<p>Kar elde etme eylemlerinin tamam\u0131 yasaklanm\u0131\u015f olmasa da, a\u015fa\u011f\u0131daki gibi d\u00fczenlemeler vard\u0131r. Nokta, bunun toplum taraf\u0131ndan kabul edilebilir bir kapsamda olup olmad\u0131\u011f\u0131d\u0131r.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>\u2460 Belirli bir plan alt\u0131nda kar elde etmeyi ama\u00e7layan ve toplumun genel anlay\u0131\u015f\u0131na g\u00f6re i\u015f olarak kabul edilebilecek d\u00fczeyde olan tekrarlanan eylemler.<\/p>\n\n\n\n<p>\u2461 T\u0131bbi kurulu\u015fun toplumsal itibar\u0131n\u0131 zedeleyebilecek olanlar (not) olmamal\u0131d\u0131r.<\/p>\n\n\n\n<p>\u2462 \u0130\u015fletmenin spek\u00fclatif bir \u015fekilde y\u00fcr\u00fct\u00fclmemesi.<\/p>\n\n\n\n<p>\u2463 \u0130lgili i\u015fi y\u00fcr\u00fctme sonucunda, ilgili t\u0131bbi kurulu\u015fun hastane, klinik veya ya\u015fl\u0131 bak\u0131m sa\u011fl\u0131k tesislerinin i\u015flerinin sorunsuz bir \u015fekilde y\u00fcr\u00fct\u00fclmesini engelleyecek bir durumun olmamas\u0131.<\/p>\n\n\n\n<p>\u2464 \u0130lgili t\u0131bbi kurulu\u015f d\u0131\u015f\u0131ndaki ki\u015filere isim \u00f6d\u00fcn\u00e7 verme veya di\u011fer haks\u0131z y\u00f6ntemlerle y\u00f6netilmemeli.<\/p>\n\n\n\n<p><br>(Not) &#8220;Toplumsal itibar\u0131n\u0131 zedeleyebilecek olanlar&#8221; aras\u0131nda, e\u011flence i\u015fletmeleri, silah \u00fcreticileri, oyun alanlar\u0131 vb. bulunmaktad\u0131r.<\/p>\n<cite><a href=\"https:\/\/www.mhlw.go.jp\/topics\/bukyoku\/isei\/igyou\/igyoukeiei\/gyoumu.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.mhlw.go.jp\/topics\/bukyoku\/isei\/igyou\/igyoukeiei\/gyoumu.pdf[ja]<\/a><\/cite><\/blockquote>\n\n\n\n<p>Belirli bir i\u015flem hakk\u0131nda, kar pe\u015finde ko\u015fmay\u0131 yasaklayan a\u00e7\u0131k bir kural yoktur. Ancak, idari uygulama olarak, kar pe\u015finde ko\u015fma ve fazla kar da\u011f\u0131t\u0131m\u0131na e\u015fde\u011fer i\u015flemler y\u00f6nlendirme hedefi olacakt\u0131r.<\/p>\n\n\n\n<p>\u00d6rne\u011fin, performansa ba\u011fl\u0131 (\u015firketin gelirine g\u00f6re \u00f6d\u00fcl belirlenen) i\u015flemler durumunda, y\u00f6nlendirme hedefi olmas\u0131na ra\u011fmen, hemen para cezas\u0131 veya di\u011fer yapt\u0131r\u0131mlar uygulanmaz. \u00d6te yandan, t\u0131bbi kurulu\u015fun gelirine ba\u011fl\u0131 olarak \u00f6deme al\u0131nan s\u00fcrekli i\u015flemler durumunda, bu durumun sorunlu g\u00f6r\u00fclme olas\u0131l\u0131\u011f\u0131 y\u00fcksektir.<\/p>\n\n\n\n<p>Bu nedenle, belirli t\u0131bbi kurulu\u015flar i\u00e7in, ilgili i\u015fletmelerle yap\u0131lan i\u015flemlerin raporlanmas\u0131 da belirlenmi\u015ftir.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Hedef_Alinan_Tibbi_Kuruluslar\"><\/span>Hedef Al\u0131nan T\u0131bbi Kurulu\u015flar<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>\u2460 Son mali y\u0131la ait bilan\u00e7onun bor\u00e7lar b\u00f6l\u00fcm\u00fcnde kaydedilen toplam tutar 50 milyar yen veya \u00fczeri veya son mali y\u0131la ait gelir tablosunun i\u015f geliri b\u00f6l\u00fcm\u00fcnde kaydedilen toplam tutar 70 milyar yen veya \u00fczeri olan t\u0131bbi kurulu\u015flar<br>\u2461 Son mali y\u0131la ait bilan\u00e7onun bor\u00e7lar b\u00f6l\u00fcm\u00fcnde kaydedilen toplam tutar 20 milyar yen veya \u00fczeri veya son mali y\u0131la ait gelir tablosunun i\u015f geliri b\u00f6l\u00fcm\u00fcnde kaydedilen toplam tutar 10 milyar yen veya \u00fczeri olan sosyal t\u0131bbi kurulu\u015flar<br>\u2462 Sosyal t\u0131bbi kurulu\u015f tahvili ihra\u00e7 eden sosyal t\u0131bbi kurulu\u015flar<br>(Yukar\u0131daki \u2460 ve \u2461&#8217;nin standartlar\u0131 olan tutarlar, valiye bildirilen bilan\u00e7o veya gelir tablosuna g\u00f6re belirlenebilir.)<\/p>\n<cite><a href=\"https:\/\/www.mhlw.go.jp\/content\/000459150.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.mhlw.go.jp\/content\/000459150.pdf[ja]<\/a><br><\/cite><\/blockquote>\n\n\n\n<p>Yukar\u0131daki durumlara uyanlar i\u00e7in, belirlenen bilan\u00e7o veya gelir tablosu format\u0131n\u0131 kullanarak, gelir raporlamas\u0131 yapman\u0131z gerekmektedir.<\/p>\n\n\n\n<p>Ayr\u0131ca, yukar\u0131daki durumlara uymayanlar i\u00e7in bile, sa\u011fl\u0131k merkezinin denetim s\u0131ras\u0131ndaki defter kontrol\u00fc veya bireysel y\u00f6nlendirmeler yap\u0131ld\u0131\u011f\u0131nda, gelire kar\u015f\u0131l\u0131k gelen \u015fekilde yap\u0131lan a\u011f\u0131zdan a\u011f\u0131za site \u00f6demelerinin izleri bulunursa, bir takip olas\u0131l\u0131\u011f\u0131 vard\u0131r.<br><\/p>\n\n\n\n<p>Yani, g\u00fczellik inceleme sitelerine inceleme kar\u015f\u0131l\u0131\u011f\u0131nda \u00f6deme yapma eylemi, t\u0131bbi kurulu\u015f taraf\u0131ndan da, T\u0131bbi Hukuka ayk\u0131r\u0131 olabilecek bir eylem oldu\u011funu anlamak gereklidir.<\/p>\n\n\n\n<p>Bu noktaya kadar olan i\u00e7eri\u011fi d\u00fczenlersek, a\u015fa\u011f\u0131daki gibi olacakt\u0131r:<\/p>\n\n\n\n<ul>\n<li>G\u00fczellik inceleme sitelerinin foto\u011fraflar\u0131 ve incelemeleri, T\u0131bbi Reklam K\u0131lavuzuna ayk\u0131r\u0131 olma olas\u0131l\u0131\u011f\u0131 y\u00fcksektir<\/li>\n\n\n\n<li>Hastanelerin \u00f6d\u00fcl kar\u015f\u0131l\u0131\u011f\u0131nda inceleme yazd\u0131rma eylemi, &#8216;kar elde etme eylemi&#8217; olarak yasaklanan T\u0131bbi Hukuka ayk\u0131r\u0131 olabilir<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Saglikla_Ilgili_Sitelerin_Karsilastirilmasi\"><\/span>Sa\u011fl\u0131kla \u0130lgili Sitelerin Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Burada, sa\u011fl\u0131kla ilgili siteleri kar\u015f\u0131la\u015ft\u0131ral\u0131m. \u015eu anda, sa\u011fl\u0131kla ilgili olarak, sa\u011fl\u0131k kurumlar\u0131ndan sistem kullan\u0131m \u00fccreti gibi adlar alt\u0131nda \u00f6deme al\u0131nan siteler a\u015fa\u011f\u0131daki gibidir:<\/p>\n\n\n\n<ul>\n<li>&#8220;Dentry&#8221; (<a href=\"https:\/\/dentry.jp\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/dentry.jp\/[ja]<\/a>)<\/li>\n\n\n\n<li>&#8220;EPARK Klinik &amp; Hastane&#8221; (<a href=\"https:\/\/fdoc.jp\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/fdoc.jp\/[ja]<\/a>)<\/li>\n\n\n\n<li>&#8220;EPARK Di\u015f Hekimli\u011fi&#8221; (<a href=\"https:\/\/haisha-yoyaku.jp\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/haisha-yoyaku.jp\/[ja]<\/a>)<\/li>\n\n\n\n<li>&#8220;Rezervasyon Premium&#8221; (<a href=\"https:\/\/www.nhosa.com\/product\/yoyaku\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.nhosa.com\/product\/yoyaku\/[ja]<\/a>)<\/li>\n\n\n\n<li>&#8220;Di\u015f Hekimli\u011fi Rezervasyon &amp; Randevu Y\u00f6netim Sistemi PROGRAM\u03b1 (Program Alpha)&#8221; (<a href=\"http:\/\/www.media-inc.co.jp\/product\/pga\/\" target=\"_blank\" rel=\"noreferrer noopener\">http:\/\/www.media-inc.co.jp\/product\/pga\/[ja]<\/a>)<\/li>\n\n\n\n<li>&#8220;Genie&#8221; (<a href=\"https:\/\/genie-dc.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/genie-dc.com\/[ja]<\/a>)<\/li>\n\n\n\n<li>&#8220;Medimo&#8221; (<a href=\"http:\/\/\u30e1\u30c7\u30a3\u30e2.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">http:\/\/\u30e1\u30c7\u30a3\u30e2.com\/[ja]<\/a>)<\/li>\n<\/ul>\n\n\n\n<p>\u203b &#8220;Medimo&#8221; bir inceleme sitesidir, di\u011ferleri rezervasyon y\u00f6netim siteleridir.<\/p>\n\n\n\n<p>Yukar\u0131dakilerden &#8220;Dentry&#8221;, kullan\u0131lan plan\u0131n farkl\u0131l\u0131\u011f\u0131na g\u00f6re sistem kullan\u0131m \u00fccreti de\u011fi\u015fir. &#8220;EPARK Klinik &amp; Hastane&#8221;, &#8220;EPARK Di\u015f Hekimli\u011fi&#8221; ve di\u011fer siteler hakk\u0131nda, web sitesinde a\u00e7\u0131klanmam\u0131\u015f olsa da, \u00f6demenin rezervasyon say\u0131s\u0131na ba\u011fl\u0131 oldu\u011fu g\u00f6r\u00fcl\u00fcyor.<\/p>\n\n\n\n<p>Son durum performansa dayal\u0131 gibi g\u00f6r\u00fcnse de, \u00f6demenin do\u011fas\u0131, &#8220;rezervasyon kabul\u00fc&#8221; ad\u0131 verilen bir temsil hizmetinin kar\u015f\u0131l\u0131\u011f\u0131d\u0131r ve gelir (\u00fccret) yerine i\u015f say\u0131s\u0131n\u0131 temel alarak, yasall\u0131\u011f\u0131 sa\u011flamak gibi bir politika oldu\u011fu d\u00fc\u015f\u00fcn\u00fclebilir. Hastanenin gelirinin \u00e7oklu\u011fu veya azl\u0131\u011f\u0131na bak\u0131lmaks\u0131z\u0131n, site \u00fczerinden \u00e7ok say\u0131da rezervasyon yap\u0131ld\u0131\u011f\u0131nda al\u0131nan \u00f6deme artar, tersine, rezervasyon say\u0131s\u0131 azald\u0131\u011f\u0131nda \u00f6deme de orant\u0131l\u0131 olarak azal\u0131r. Bu t\u00fcr bir sistemle, hastanenin geliriyle ili\u015fkisi zay\u0131flar, bu nedenle performansa dayal\u0131 olmayabilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Saglik_kurumlarindan_inceleme_karsiliginda_odul_almak_yasal_mi\"><\/span>Sa\u011fl\u0131k kurumlar\u0131ndan inceleme kar\u015f\u0131l\u0131\u011f\u0131nda \u00f6d\u00fcl almak yasal m\u0131?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2020\/07\/medical-institution-reward-law4.jpg\" alt=\"\" class=\"wp-image-14442\" \/><\/figure>\n\n\n\n<p>Yukar\u0131daki sa\u011fl\u0131k kurumu sitesinin \u00f6rne\u011fine bakarsak, yorum siteleri durumunda, \u00f6rne\u011fin &#8220;Site yorumlar\u0131n\u0131 okuyup rezervasyon yapt\u0131m&#8221; diyen hastalar\u0131n say\u0131s\u0131na g\u00f6re \u00f6d\u00fcl miktar\u0131n\u0131 de\u011fi\u015ftiren bir s\u00f6zle\u015fme i\u00e7eri\u011fi yaparsan\u0131z, \u00f6d\u00fcl\u00fcn niteli\u011fi, siteye yorum yay\u0131nlama gibi somut bir i\u015fin kar\u015f\u0131l\u0131\u011f\u0131 olur ve performansa dayal\u0131 oldu\u011fu de\u011ferlendirmesinden ka\u00e7\u0131n\u0131labilir. Ancak bu durumda, i\u015f i\u00e7eri\u011fi sa\u011fl\u0131k kurumundan yorum yay\u0131nlama g\u00f6revi almak olaca\u011f\u0131 i\u00e7in, yorumlar\u0131n reklam olabilece\u011fi ve yukar\u0131da belirtti\u011fimiz Japon Sa\u011fl\u0131k Reklam\u0131 K\u0131lavuzu&#8217;ndaki sorunla kar\u015f\u0131 kar\u015f\u0131ya kal\u0131rs\u0131n\u0131z.<\/p>\n\n\n\n<p>Japon Sa\u011fl\u0131k Reklam\u0131 K\u0131lavuzu&#8217;nda reklam\u0131n tan\u0131m\u0131 a\u015fa\u011f\u0131daki gibidir:<\/p>\n\n\n\n<ul>\n<li>Hasta kabul\u00fcn\u00fc te\u015fvik etme niyeti olmas\u0131 (te\u015fvik edicilik)<\/li>\n\n\n\n<li>T\u0131bbi veya di\u015f hekimli\u011fi hizmeti sunan ki\u015finin ad\u0131 veya unvan\u0131 veya hastane veya klini\u011fin ad\u0131n\u0131n belirlenebilir olmas\u0131 (belirlenebilirlik)<\/li>\n<\/ul>\n\n\n\n<p>\u0130\u015f i\u00e7eri\u011fini sa\u011fl\u0131k kurumu belirlerse, yukar\u0131daki maddeleri kar\u015f\u0131lar ve reklam olarak kabul edilme olas\u0131l\u0131\u011f\u0131 y\u00fcksektir. Ba\u015flang\u0131\u00e7ta, Japon Sa\u011fl\u0131k Reklam\u0131 K\u0131lavuzu&#8217;ndaki reklamlar\u0131n kapsam\u0131na girerse, para \u00f6demesi e\u015fli\u011finde inceleme vb. yay\u0131nlama talepleri yasak maddelere ayk\u0131r\u0131 oldu\u011fu i\u00e7in, k\u0131lavuz ihlali olma riski y\u00fcksektir, bunu a\u00e7\u0131klad\u0131\u011f\u0131m\u0131z gibi.<\/p>\n\n\n\n<p>Yani, performansa dayal\u0131 ve s\u00f6zle\u015fme i\u00e7eri\u011fi ile \u00f6d\u00fcl\u00fc de\u011fi\u015ftiren durumlar aras\u0131nda, her iki durumda da hukuki risk y\u00fcksektir.<br><\/p>\n\n\n\n<p>Bu durumu g\u00f6z \u00f6n\u00fcnde bulundurarak, sa\u011fl\u0131k ofisleri vb. ile bir kez anonim olarak ileti\u015fime ge\u00e7mek ve sorun olup olmad\u0131\u011f\u0131n\u0131 kontrol etmek iyi olacakt\u0131r. Yorum sitesini arac\u0131 olarak kullan\u0131yor olsan\u0131z bile, sa\u011fl\u0131k kurumunun yorum yapanlara, yorumun kar\u015f\u0131l\u0131\u011f\u0131 olarak \u00f6d\u00fcl \u00f6demesi ve bunun \u00f6z\u00fcnde bir fark yoktur. Japon Sa\u011fl\u0131k Hukuku&#8217;nun 54. maddesinde sa\u011fl\u0131k kurumlar\u0131n\u0131n as\u0131l i\u015flerinin d\u0131\u015f\u0131nda gelir elde etmesinin, belirli durumlar d\u0131\u015f\u0131nda yasak oldu\u011funu g\u00f6z \u00f6n\u00fcnde bulundurursak, bu olduk\u00e7a gri bir eylemdir. Site i\u015fletmeyi s\u00fcrd\u00fcr\u00fcrken riski \u00f6nlemek istiyorsan\u0131z, uygun kurumlara \u00f6nceden dan\u0131\u015fma kesin bir se\u00e7enek olacakt\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ozet\"><\/span>\u00d6zet<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>G\u00fczellikle ilgili yorum sitelerinin i\u015fletilmesinde, t\u0131bbi kurulu\u015flardan yorum kar\u015f\u0131l\u0131\u011f\u0131 \u00f6d\u00fcl alman\u0131n hukuki risklerini inceledik.<\/p>\n\n\n\n<p>\u00d6ncelikle, yorumlar\u0131n ve foto\u011fraflar\u0131n Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k Y\u00f6nergeleri&#8217;nin yasaklar\u0131na ayk\u0131r\u0131 olup olmad\u0131\u011f\u0131 tart\u0131\u015fma konusu olabilir ve ayr\u0131ca hastane taraf\u0131ndan da, yorum kar\u015f\u0131l\u0131\u011f\u0131 \u00f6d\u00fcl \u00f6deme eyleminin Japon Sa\u011fl\u0131k Hukuku&#8217;nda d\u00fczenlenen eylemlere uygun olup olmad\u0131\u011f\u0131 da m\u00fcmk\u00fcnd\u00fcr.<\/p>\n\n\n\n<p>Performansa ba\u011fl\u0131 \u00f6d\u00fcl sistemi uygulan\u0131p uygulanmad\u0131\u011f\u0131 \u00f6nemli bir noktad\u0131r, ancak bu \u00e7ok zor bir durumdur. Kendi ba\u015f\u0131n\u0131za karar vermek yerine, \u00f6nceden uzman bir avukata dan\u0131\u015fman\u0131z\u0131 \u00f6neririz.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>G\u00fczellik esteti\u011fi yapt\u0131ran hastalardan bir\u00e7ok yorum ve inceleme al\u0131nan g\u00fczellik odakl\u0131 yorum siteleri. Son zamanlarda, \u00e7e\u015fitli yorum sitelerinin say\u0131s\u0131 artm\u0131\u015ft\u0131r, ancak bunlar\u0131n i\u00e7inde, inceleme yay\u0131n [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":64005,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[21,41],"acf":[],"_links":{"self":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61685"}],"collection":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/comments?post=61685"}],"version-history":[{"count":3,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61685\/revisions"}],"predecessor-version":[{"id":64006,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61685\/revisions\/64006"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media\/64005"}],"wp:attachment":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media?parent=61685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/categories?post=61685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/tags?post=61685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}